Late last week, UVA announced it will launch a biotechnology institute, the Paul and Diane Manning Institute of Biotechnology, with a $100 million donation from Charlottesville investor Paul Manning and his wife, Diane. UVA will also contribute $150 million, and the state of Virginia has allocated $50 million in initial investments for the institute in its 2022-24 budget.
Sponsored by the not-for-profit Uplifting Athletes, the Young Investigators Draft provides $20,000 grants to 10 beginning-career stage research scientists in the rare disease community. The award is an unrestricted grant that will support the vital investigation of potential therapies and cures, including gene therapies, for rare disease, said Rob Long, executive director of Uplifting Athletes.
Focused on treating hypertension, Radnor, PA-based Mineralys Therapeutics filed with the SEC for an initial public offering (IPO). Although specifics of the launch have not been published, the company’s Filing Fee Table indicates the IPO could be for up to $100 million.
Leap Therapeutics, headquartered in Cambridge, Mass., acquired New Hope, Pa.-based Flame Biosciences. The primary focus of the merger was for Leap to pick up Flame’s FL-301, a clinical-stage anti-Claudin18.2 monoclonal antibody.
As Maryland continues to blossom as a medtech powerhouse, TEDCO has played an instrumental role in providing capital, resources and mentorship. This was especially true in q4 2022, where TEDCO invested over $1 million combined into LASARRUS, Linshom Medical, NanoBioFAB, CoolTech and Mi-Helper.
In Prince William County, 2023 is kicking off with a new round of IGNITE Startup Grants that will provide funding for high-growth entrepreneurs who want to call the area home.
TEDCO, Maryland’s economic engine for technology companies, announced today its Builder Fund invested $100,000 in SeeTrue Technology, LLC, a woman-led company seeking to revolutionize the biomedical industry with its micro-injection technology.
Hood College is proud to announce that The Hodson Trust has gifted $2.3M to the College for use in the Hodson Science and Technology Center expansion project.
This project includes a 32,000-gross-square-foot addition, which includes a new Biomedical Research and Training Center to accommodate growth in STEM programs. The Hodson Science and Technology Center was originally constructed in 1957, with additional renovation projects completed in 2000 and 2014.
TEDCO, Maryland’s economic engine for technology companies, is pleased to announce its Venture Funds invested nearly $1M in Warrior Centric Health (WCH), an organization that enables healthcare facilities and providers to deliver optimal care to 75 million veterans, active service members, and their families. TEDCO’s evergreen Venture Funds are dedicated to funding and growing the next generation of early-stage businesses in Maryland.
Peroxitech Announces Closing of $25M Series A Financing to Develop Novel Treatment for Acute Lung Injury
Peroxitech Inc., an emerging biopharmaceutical company developing a novel peptide for treating acute lung injury (ALI), announced the successful completion of a Series A financing round of $25 million led by the Perceptive Xontogeny Venture Fund (“PXV Fund”). The company will use the proceeds to build upon the preclinical work conducted through collaborative partnership and seed investment with the Xontogeny development team to advance the lead candidate, PIP-2, through IND-enabling studies and into clinical development.